-+ 0.00%
-+ 0.00%
-+ 0.00%

IDEX (IEX) Following Strong Q2 Results Still Looks Undervalued To Some Investors

Simply Wall St·08/02/2026 13:23:31
语音播报

IDEX (IEX) reported second quarter 2026 results that included US$920.6 million in sales and US$143.4 million in net income, along with higher earnings per share from continuing operations compared with the same period last year.

See our latest analysis for IDEX.

IDEX shares trade at US$230.45 after a small pullback over the past day. The stock has a 28.70% year to date share price return and a 46.98% total shareholder return over the past year, which points to momentum that has built alongside recent earnings and ongoing share repurchases.

If you are interested in how other industrial and engineering companies are priced and growing, broadening your search with the 35 power grid technology and infrastructure stocks can be a useful next step.

After a strong year for IDEX shares and a modest pullback in the latest session, the current US$230.45 price still sits below both intrinsic and analyst estimates. How much potential upside does that spread represent?

Most Popular Narrative: 7.1% Undervalued

The most followed narrative for IDEX compares a fair value of $248 to the current $230.45 share price, which suggests some remaining upside in the story.

The company is implementing proactive cost-saving measures, targeting $20 million in savings on top of previous initiatives. This focus on platform optimization and organizational delayering may improve net margins by reducing operating expenses.

Read the complete narrative.

Want to understand why this IDEX view still arrives at a higher fair value than today’s price? The heart of the narrative blends steady revenue growth, rising margins, and a richer earnings profile than the market currently prices in.

The narrative behind IDEX uses an 8.44% discount rate and ties expected revenue growth, margin expansion and future earnings to a fair value of $248 per share. Analysts in this narrative also assume the company continues reducing its share count, which supports earnings per share over time and helps justify a future earnings multiple above the wider US market assumptions included in the model.

Behind that single fair value figure sit several moving parts that you can weigh against your own expectations, including how quickly sales grow from the current US$3.6b base and how much of that converts into profit. The narrative also assumes the future P/E settles below today’s level but remains above the broader US Machinery industry, which is an important hinge in the valuation.

Result: Fair Value of $248 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, IDEX investors still need to watch tariffs that could pressure margins, as well as any further softness in sectors like semiconductors and agriculture that could unsettle revenue.

Find out about the key risks to this IDEX narrative.

Another View on IDEX Using Market Multiples

The SWS DCF model points to IDEX trading 17.2% below an estimated fair value of $278.36. However, the current P/E of 32.7x is higher than the Machinery industry at 27.3x, the peer average at 29x, and the fair ratio of 27.1x. Does that premium signal quality or valuation risk for you?

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:IEX P/E Ratio as at Aug 2026
NYSE:IEX P/E Ratio as at Aug 2026

Next Steps

If the mix of positive signals around IDEX has you curious, take a closer look at the data and move quickly to form your own view. To see what optimists are focusing on, start with these 3 key rewards

Looking For More Investment Ideas Beyond IDEX?

If IDEX has sharpened your interest in opportunities, do not stop here. Use focused stock ideas to keep building a watchlist that truly matches your goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.